Insmed (INSM) PT Raised to $203 at RBC Capital
RBC Capital analyst Leonid Timashev raised the price target on Insmed (NASDAQ: INSM) to $203.00 (from $200.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
